drug

Nimodipine

MeSH D009553
as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Johns Hopkins University
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
small molecule

Indications

Trials

1
Cognitive Effects of Nimodipine in Patients With Schizophrenia
NCT03671525Early Phase 1Completed

KOLs & investigators

1
Kristin Bigos, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Johns Hopkins University
company
trial
Cognitive Effects of Nimodipine in Patients With Schizophrenia
EARLY_PHASE1
trial
indication
Schizophrenia
indication
Schizo Affective Disorder
indication
Schizophrenia
indication
Psychotic Disorders
indication
KOL
Kristin Bigos, PhD
KOL score —
person